Found 17 matching trials
Study on Pharmacokinetics PHASE1 The purpose of this study is to assess the effect of the coadministration o...
Show More Location
Multiple Locations
Learn More & Join Trial
Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy Subjects PHASE1 A single oral dose study in subjects with hepatic impairment and healthy co...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone PHASE1 The study is being conducted to assess the effect of multiple doses of BMS-...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI) PHASE1 This is an open-label, single sequence, 2-cohort, drug-drug interaction stu...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1 PHASE2 Research Hypothesis: Administration of BMS-663068, a prodrug for HIV attach...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet PHASE1 This 2-part study will determine the bioavailability of BMS-626529 in healt...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects PHASE1 An oral dose in healthy subjects to determine the relative bioavailabilty o...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy Subjects PHASE1 The purpose of this study is to estimate the effect of high fat meal and in...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Drug-drug Interaction (DDI) Rifabutin PHASE1 The purpose of this study is to provide dosing recommendations for the coad...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients PHASE3 The purpose of this study is to determine whether the BMS Attachment Inhibi...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial